Your browser doesn't support javascript.
Acute pancreatitis associated with severe acute respiratory syndrome coronavirus-2 infection: a case report and review of the literature.
Eldaly, Abdullah S; Fath, Ayman R; Mashaly, Sarah M; Elhadi, Muhammed.
  • Eldaly AS; Plastic and Reconstructive Surgery Department, Tanta University Hospital, Tanta, Egypt.
  • Fath AR; Internal Medicine Department, Creighton University Arizona Health Education Alliance, Phoenix, AZ, USA.
  • Mashaly SM; Elmenshawy General Hospital, Tanta, Egypt.
  • Elhadi M; Faculty of Medicine, University of Tripoli, University Road, Furnaj, 13275, Tripoli, Libya. muhammed.elhadi.uot@gmail.com.
J Med Case Rep ; 15(1): 461, 2021 Sep 09.
Article in English | MEDLINE | ID: covidwho-1403258
ABSTRACT

INTRODUCTION:

We report a case of Severe acute respiratory syndrome coronavirus-2 infection with acute pancreatitis as the only presenting symptom. To the best of our knowledge, there are few case reports of the same presentation. CASE PRESENTATION An otherwise healthy 44-year-old white male from Egypt presented to the hospital with severe epigastric pain and over ten attacks of nonprojectile vomiting (first, gastric content, then bilious). Acute pancreatitis was suspected and confirmed by serum amylase, serum lipase, and computed tomography scan that showed mild diffuse enlargement of the pancreas. The patient did not have any risk factor for acute pancreatitis, and extensive investigations did not reveal a clear etiology. Given a potential occupational exposure, a nasopharyngeal swab for polymerase chain reaction testing for severe acute respiratory syndrome coronavirus 2 was done, which was positive despite the absence of the typical symptoms of severe acute respiratory syndrome coronavirus 2 such as fever and respiratory symptoms. The patient was managed conservatively. For pancreatitis, he was kept nil per os for 2 days and received intravenous lactated Ringer's (10 ml per kg per hour), nalbuphine, alpha chymotrypsin, omeprazole, and cyclizine lactate. For severe acute respiratory syndrome coronavirus 2, he received a 5-day course of intravenous azithromycin (500 mg per day). He improved quickly and was discharged by the fifth day. We know that abdominal pain is not a rare symptom of severe acute respiratory syndrome coronavirus 2, and we also know that elevated levels of serum amylase and lipase were reported in severe acute respiratory syndrome coronavirus-2 patients, especially those with severe symptoms. However, the association between severe acute respiratory syndrome coronavirus-2 infection and idiopathic acute pancreatitis is rare and has been reported only a few times.

CONCLUSION:

We believe further studies should be conducted to determine the extent of pancreatic involvement in severe acute respiratory syndrome coronavirus-2 patients and the possible causality between severe acute respiratory syndrome coronavirus 2 and acute pancreatitis. We reviewed the literature regarding the association between severe acute respiratory syndrome coronavirus 2 and acute pancreatitis patients. Published data suggest that severe acute respiratory syndrome coronavirus 2 possibly could be a risk factor for acute pancreatitis.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatitis / COVID-19 Type of study: Case report / Diagnostic study / Etiology study / Prognostic study Limits: Adult / Humans / Male Language: English Journal: J Med Case Rep Year: 2021 Document Type: Article Affiliation country: S13256-021-03026-7

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pancreatitis / COVID-19 Type of study: Case report / Diagnostic study / Etiology study / Prognostic study Limits: Adult / Humans / Male Language: English Journal: J Med Case Rep Year: 2021 Document Type: Article Affiliation country: S13256-021-03026-7